Dr. Jeremy M. Kilburn
Claim this profileGibbs Cancer Center-Pelham
Studies Tumors
Studies Lung Cancer
7 reported clinical trials
14 drugs studied
Area of expertise
1Tumors
Stage IV
Stage II
Stage III
2Lung Cancer
Stage IV
Stage I
Stage II
Affiliated Hospitals
Clinical Trials Jeremy M. Kilburn is currently running
Surgery and Radiation vs. Radiation Alone
for Brain Cancer
This phase III trial compares the addition of stereotactic radiosurgery before or after surgery in treating patients with cancer that has spread to the brain (brain metastases). Stereotactic radiosurgery is a type of radiation therapy that delivers a high dose of radiation only to the small areas of cancer in the brain and avoids the surrounding normal brain tissue. Surgery and radiation may stop the tumor from growing for a few months or longer and may reduce symptoms of brain metastases.
Recruiting2 awards Phase 3
Single vs Multiple Dose Radiation
for Brain Metastases
This study is designed to see if we can lower the chance of side effects from radiation in patients with breast, kidney, small cell lung cancer, non-small cell lung cancer or melanoma that has spread to the brain and who are also being treated with immunotherapy, specifically immune checkpoint inhibitor (ICI) therapy. This study will compare the usual care treatment of single fraction stereotactic radiosurgery (SSRS) given on one day versus fractionated stereotactic radiosurgery (FSRS), which is a lower dose of radiation given over a few days to determine if FSRS is better or worse at reducing side effects than usual care treatment.
Recruiting1 award N/A
More about Jeremy M. Kilburn
Clinical Trial Related2 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Jeremy M. Kilburn has experience with
- Stereotactic Radiosurgery
- FSRS
- SSRS
- Atezolizumab
- Stereotactic Body Radiation Therapy
- Data Collection
Breakdown of trials Jeremy M. Kilburn has run
Tumors
Lung Cancer
Cancer
Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jeremy M. Kilburn specialize in?
Jeremy M. Kilburn focuses on Tumors and Lung Cancer. In particular, much of their work with Tumors has involved Stage IV patients, or patients who are Stage II.
Is Jeremy M. Kilburn currently recruiting for clinical trials?
Yes, Jeremy M. Kilburn is currently recruiting for 4 clinical trials in East Chicago Indiana. If you're interested in participating, you should apply.
Are there any treatments that Jeremy M. Kilburn has studied deeply?
Yes, Jeremy M. Kilburn has studied treatments such as Stereotactic Radiosurgery, FSRS, SSRS.
What is the best way to schedule an appointment with Jeremy M. Kilburn?
Apply for one of the trials that Jeremy M. Kilburn is conducting.
What is the office address of Jeremy M. Kilburn?
The office of Jeremy M. Kilburn is located at: Gibbs Cancer Center-Pelham, East Chicago, Indiana 46312 United States. This is the address for their practice at the Gibbs Cancer Center-Pelham.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.